Can Ozempic Make You Go Blind? Eye Doctor Explains New Research [Expert Interview]

Date: 2026-10-14 15:40:23

×

Can Ozempic cause blindness? I sit down with a leading eye doctor and researcher to break down what we actually know about GLP-1 medications and the risk of sudden vision loss from NAION.

If you take Ozempic, Wegovy, Mounjaro, or another GLP-1, or are thinking about starting one, this conversation explains the real eye risks, who should be most cautious, and what to ask your eye doctor before you worry.

In this episode, we cover:
-Can Ozempic cause blindness and optic nerve damage?
-Is this a semaglutide issue or a risk for the entire GLP-1 class?
-NAION symptoms: what blurry vision or vision loss looks like and when to seek emergency care vs. see your optometrist
-How much vision loss NAION causes, can it affect both eyes, and is optic nerve damage reversible?
-Why GLP-1s might be linked to NAION and potential mechanisms
-When you are most vulnerable after starting or increasing dose, and is risk dose-dependent?
-Who is high-risk?
-Should everyone starting a GLP-1 get a baseline eye exam?
-Can you prevent NAION?

Key Takeaways
🔹 NAION typically causes sudden, painless vision loss in one eye. Symptoms may include missing areas of vision, dim or blurry sight, and reduced color perception.
🔹 The reported risk remains low, but certain studies suggest GLP-1 use may increase the risk of NAION. Individual risk depends on eye anatomy, medical history, and cardiovascular health.
🔹 People over 50 and those with diabetes, high blood pressure, high cholesterol, cardiovascular disease, glaucoma, macular degeneration, or existing diabetic retinopathy may require closer monitoring.
🔹 Do not stop or change a prescribed GLP-1 medication without speaking with your healthcare professional. Seek urgent medical attention for sudden vision loss or a new missing area in your visual field.

✅ Watch Next:
GLP-1 Blindness Risk: Should You Be Worried?

This Is What Sugar Does to Your Eyes

5 Signs and Symptoms of Diabetic Eye Disease

Why You Need an Eye Exam

About Our Guest
Dr. Andrew Morgenstern is an optometrist and clinical educator who has served as a subject-matter expert with the United States Defense Health Agency’s Vision Center of Excellence. He is also a clinician at Walter Reed, an assistant professor of surgery at the Uniformed Services University, and director of the American Optometric Association’s Evidence-Based Optometry Committee.
Website: https://andrewmorgenstern.com/
LinkedIn: https://www.linkedin.com/in/andrewmorgenstern/

Research Mentioned
American Optometric Association GLP-1 Clinical Report:
https://www.aoa.org/AOA/Documents/Practice%20Management/Clinical%20Guidelines/AOA%20GLP-1_EBO_clinical-report.pdf
Semaglutide and the Risk of NAION:
https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2820255
GLP-1 Medications and Macular Degeneration:
https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2834964
Semaglutide and Diabetic Retinopathy:
https://www.nejm.org/doi/10.1056/NEJMoa1607141

📩 Join our Free Newsletter to stay up to date about eye health and vision: https://doctor-eye-health.aweb.page/see-your-best-eyes-shine

👨‍⚕️ ABOUT DR. ALLEN, OD, FAAO, Dipl ABO
Dr. Joseph Allen is a board-certified optometrist and the creator of Doctor Eye Health, where he shares trustworthy, easy-to-understand videos on eye health, vision care, and treatment options.

DISCLAIMER: All content in this video and description including infor­ma­tion, opinions, con­tent, ref­er­ences, and links is for infor­ma­tional pur­poses only. You should con­sult a licensed physi­cian or appropriately-credentialed health care worker in your com­mu­nity in all mat­ters relat­ing to your health. Also, some of the links in this post may be affiliate links, meaning, at no cost to you, I will earn a small commission if you click through and make a purchase. But if you click, it really helps me make more of these videos! All non-licensed clips used for fair use commentary, criticism, and educational purposes.

Timestamps
00:00 Can Ozempic cause blindness?
02:12 Is vision risk limited to semaglutide?
04:30 Understanding NAION and optic nerve strokes
09:35 Warning signs of NAION
11:41 Should you call an eye doctor or visit the emergency room?
15:45 Can vision recover after NAION?
18:21 Low-vision rehabilitation and protecting the second eye
21:11 When GLP-1-related eye complications may occur
24:20 Blood sugar, A1C, and gradual dose increases
28:19 What current research says about absolute risk
31:35 Who may be at greater risk?
34:32 What is a “disc at risk”?
38:37 Diabetic retinopathy and macular degeneration
41:47 Why annual dilated eye exams matter
45:24 Benefits of GLP-1 medications
48:51 Understanding single, double, and triple agonist drugs
51:33 Final eye-health and prevention recommendations

#ozempic #naion #eyedoctor